Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Mind over shoulder: study probes why some recover from chronic pain and others Don't

NCT ID NCT07654023

Knowledge-focused Sponsor: Pamukkale University Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how central sensitization (a heightened pain response) and psychological factors like pain catastrophizing influence recovery in people with chronic shoulder pain. Participants will undergo a standard 6-week physiotherapy program, and researchers will measure pain, disability, and related symptoms before and after treatment. The goal is to better understand why some people improve more than others, which could lead to more personalized rehabilitation approaches.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
Physiotherapy Rehabilitation Program
What this could lead to
If successful, this could help tailor rehabilitation programs to individual psychological and pain-processing profiles, improving outcomes for people with chronic shoulder pain.
What could go wrong
This is an observational study, not a treatment trial. It may identify factors that influence recovery, but it won't test a new therapy or guarantee better results for participants.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Participants

About 59 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Jun 2026

An estimate. Start dates often move.

Expected to finish

Aug 2026

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Who is studied

Adults with chronic shoulder pain who are referred to physiotherapy and rehabilitation clinics and scheduled to receive a standardized 6-week physiotherapy rehabilitation program. Participants will include individuals with shoulder pain associated with conditions such as rotator cuff-related shoulder pain, subacromial pain syndrome, and adhesive capsulitis.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults aged 18 years and older * Presence of chronic shoulder pain lasting at least 3 months * Clinical findings consistent with shoulder-related pain * Willingness to participate in a 6-week physiotherapy rehabilitation program * Ability to complete study assessments and questionnaires * Provision of written informed consent Exclusion Criteria: * History of shoulder surgery within the previous 6 months * Major shoulder trauma within the previous 6 months * Serious pathology affecting the shoulder (e.g., infection, tumor, systemic inflammatory disease) * Neurological disorders affecting the upper extremity (e.g., cervical radiculopathy, myelopathy, peripheral nerve injury) * Severe cognitive impairment * Communication problems preventing participation * Shoulder injection within the previous 4 weeks * Pregnancy

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Chronic shoulder pain are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Chronic shoulder pain

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Burdur Mehmet Akif Ersoy Üniversitesi

    Burdur, Türkiye, 19300, Turkey (Türkiye)

More trials for these conditions

Other studies related to the condition(s) this trial covers.